Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Sarcoma and Mut[original query] |
---|
Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer. Human pathology 2012 Oct 43 (10): 1573-82. Juanpere Nuria, Agell Laia, Lorenzo Marta, de Muga Silvia, López-Vilaró Laura, Murillo Raquel, Mojal Sergi, Serrano Sergio, Lorente José A, Lloreta Josep, Hernández Silv |
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Dec . Zer Alona, Ding Keyue, Lee Siow Ming, Goss Glenwood D, Seymour Lesley, Ellis Peter M, Hackshaw Allan, Bradbury Penelope A, Han Lei, O'Callaghan Christopher J, Tsao Ming-Sound, Shepherd Frances |
Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways. British journal of cancer 2020 Mar . Amitay Efrat L, Carr Prudence R, Jansen Lina, Roth Wilfried, Alwers Elizabeth, Herpel Esther, Kloor Matthias, Bläker Hendrik, Chang-Claude Jenny, Brenner Hermann, Hoffmeister Micha |
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial. Clinical chemistry 2020 Nov . Lueong Smiths S, Herbst Andreas, Liffers Sven-Thorsten, Bielefeld Nicola, Horn Peter A, Tannapfel Andrea, Reinacher-Schick Anke, Hinke Axel, Hegewisch-Becker Susanna, Kolligs Frank T, Siveke Jens |
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
Mutational landscape of primary and recurrent Ewing sarcoma. Contemporary oncology (Poznan, Poland) 2022 1 25 (4): 241-248. Jagodzi?ska-Mucha Paulina, Sobczuk Pawe?, Miku?a Micha?, Raciborska Anna, Dawidowska Anna, Kulecka Maria, Bilska Katarzyna, Szumera-Cie?kiewicz Anna, Kluska Anna, Pi?tkowska Magdalena, Ba?abas Anna, Rutkowski Piotr, ?ugowska Iwo |
Histologic and immunologic factors associated with response to immune checkpoint inhibitors in advanced sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 12 . Alex Q Lee, Clara Hao, Minggui Pan, Kristen N Ganjoo, Nam Q B |
- Page last reviewed:Feb 1, 2024
- Content source: